CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced they will present a poster on clinical applications at the upcoming North American Neuromodulation Society (NANS) 13th Annual Meeting this week in Las Vegas, Nevada.
NANS is dedicated to advancing the field of Neuromodulation through clinical research, education, and print material within the United States while increasing the avenues of development for its members through professional networking systems, ongoing communication and other opportunities.
“The poster will focus on our efforts in developing our technology to treat chronic pain,” stated Jon J. Snyder, President and CEO of Neuros Medical. “While we are in the early stages of commercialization, it’s important to communicate to the members of key organizations such as NANS of our efforts so that we can continue to work together in eventually providing this technology to their patients.”
Dr. Amol Soin of The Ohio Pain Clinic, a network of chronic pain treatment centers in Southwest Ohio, and the recently named head of the Clinical Advisory Board for Neuros Medical, will present the poster during the viewing session on Friday December 4th.
“This poster is an important opportunity to engage the thought leaders in the industry,” said Dr. Soin. “It provides a great stage for discussion and creating awareness to my fellow colleagues of the important technology development underway at Neuros Medical.”
About Neuros Medical, Inc.
Neuros Medical, a Cleveland, Ohio based neurostimulation company, is focused on developing proprietary neurostimulation therapies for unmet needs to patients worldwide. The company’s patented platform technology, Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post surgical pain, and chronic migraine.